Search Results for: Solid residue in form of pellets
metastatic non-small cell lung cancer regardless of kras mutational status december 9, 2019 merck to acquire arqule, advancing leadership in oncology december 5, 2019 lynparza(r) (olaparib) approved in china as a first-line maintenance therapy in brca-mutated (brcam) advanced ovarian cancer view all
news events & presentations earnings investor event other view all events forward-looking statement of merck & co., inc., kenilworth, n.j., usa this news release of merck & co., inc., kenilworth, n.j., usa (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions...
https://investors.merck.com/home/default.aspx